Category Archives: Pharmaceuticals

Top Stories for Week of February 24, 2020

      No Comments on Top Stories for Week of February 24, 2020

TOP  STORIES Aided by machine learning (AI), scientists find novel antibiotic able to kill superbugs. A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world… Read more »

China records more than 2,000 new coronavirus cases in 24 hours; CDC director says CIVUD-19 probably with us beyond this year.

The News: China’s National Health Commission on Monday reported 2,048 new cases of coronavirus infections and 105 new deaths over the previous 24 hours. The number of new deaths dropped… Read more »

Medical Stock Spotlight – market’s stampede into stocks that could, even remotely, benefit from the coronavirus outbreak

Thinly traded nano cap Cleveland BioLabs Inc. (Nasdaq:CBLI) led advancing issues, skyrocketing 220% over the week to $4.23 as yet another company is caught up in the market’s stampede into… Read more »

Trump changes Medicaid

      No Comments on Trump changes Medicaid

The News: The Trump administration on Thursday (February 6, 2020) said it will experiment with allowing state Medicaid programs to limit health benefits and prescription drug coverage for some patients… Read more »

Drug regulators in China, US and Europe out of the gates in 2020 with a whole month’s worth of action.

Slowly at first, then accelerating recently in its domestic and global footprint in drug research and regulation, China and its National Medical Products Administration (NMPA) has been on a tear…. Read more »

Health-sector IPO action picks up where 2019 left off with new SEC filings signaling high hopes for cash still parked on the sidelines.

Despite clashes over trade sanctions pending resolution with China and threats of war with Iran escalating to nerve-wracking heights, confidence in the US market for health-sector initial public offerings apparently… Read more »

China’s BeiGene gets nod from FDA for lymphoma med; significance extends further than just a win for one Chinese biotech.

The News: The US Food and Drug Administration has given the green light to market a blood cancer drug from Beijing-based BeiGene Ltd., paving the way for American patients to access a Chinese… Read more »

FDA panel unanimously backs use of Amarin’s fish-oil heart drug; action could produce gigantic profit haul.

The News: Government health experts recently recommended broader use of a prescription-strength fish oil drug to help many more patients at risk for heart attack, stroke and related health problems…. Read more »

In a seeming role-reversal, FDA steps up action over Thanksgiving week while EMA goes on holiday.

Although usually thought of as a well-deserved respite from governmental rulings, the US Food and Drug Administration seized on Thanksgiving week as a demonstration of its zeal to pump out… Read more »